These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8662847)
1. Insulin regulates heregulin binding and ErbB3 expression in rat hepatocytes. Carver RS; Sliwkowski MX; Sitaric S; Russell WE J Biol Chem; 1996 Jun; 271(23):13491-6. PubMed ID: 8662847 [TBL] [Abstract][Full Text] [Related]
2. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. Sliwkowski MX; Schaefer G; Akita RW; Lofgren JA; Fitzpatrick VD; Nuijens A; Fendly BM; Cerione RA; Vandlen RL; Carraway KL J Biol Chem; 1994 May; 269(20):14661-5. PubMed ID: 7514177 [TBL] [Abstract][Full Text] [Related]
3. The structural basis for the specificity of epidermal growth factor and heregulin binding. Barbacci EG; Guarino BC; Stroh JG; Singleton DH; Rosnack KJ; Moyer JD; Andrews GC J Biol Chem; 1995 Apr; 270(16):9585-9. PubMed ID: 7721889 [TBL] [Abstract][Full Text] [Related]
4. The erbB3 gene product is a receptor for heregulin. Carraway KL; Sliwkowski MX; Akita R; Platko JV; Guy PM; Nuijens A; Diamonti AJ; Vandlen RL; Cantley LC; Cerione RA J Biol Chem; 1994 May; 269(19):14303-6. PubMed ID: 8188716 [TBL] [Abstract][Full Text] [Related]
5. Binding interaction of the heregulinbeta egf domain with ErbB3 and ErbB4 receptors assessed by alanine scanning mutagenesis. Jones JT; Ballinger MD; Pisacane PI; Lofgren JA; Fitzpatrick VD; Fairbrother WJ; Wells JA; Sliwkowski MX J Biol Chem; 1998 May; 273(19):11667-74. PubMed ID: 9565587 [TBL] [Abstract][Full Text] [Related]
6. Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4. Fitzpatrick VD; Pisacane PI; Vandlen RL; Sliwkowski MX FEBS Lett; 1998 Jul; 431(1):102-6. PubMed ID: 9684874 [TBL] [Abstract][Full Text] [Related]
7. Heregulin-stimulated signaling in rat pheochromocytoma cells. Evidence for ErbB3 interactions with Neu/ErbB2 and p85. Gamett DC; Greene T; Wagreich AR; Kim HH; Koland JG; Cerione RA J Biol Chem; 1995 Aug; 270(32):19022-7. PubMed ID: 7642563 [TBL] [Abstract][Full Text] [Related]
8. Selection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage display. Ballinger MD; Jones JT; Lofgren JA; Fairbrother WJ; Akita RW; Sliwkowski MX; Wells JA J Biol Chem; 1998 May; 273(19):11675-84. PubMed ID: 9565588 [TBL] [Abstract][Full Text] [Related]
9. Mutation of a Shc binding site tyrosine residue in ErbB3/HER3 blocks heregulin-dependent activation of mitogen-activated protein kinase. Vijapurkar U; Cheng K; Koland JG J Biol Chem; 1998 Aug; 273(33):20996-1002. PubMed ID: 9694850 [TBL] [Abstract][Full Text] [Related]
10. Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3. Carraway KL; Soltoff SP; Diamonti AJ; Cantley LC J Biol Chem; 1995 Mar; 270(13):7111-6. PubMed ID: 7535767 [TBL] [Abstract][Full Text] [Related]
11. Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1. Hutcheson IR; Goddard L; Barrow D; McClelland RA; Francies HE; Knowlden JM; Nicholson RI; Gee JM Breast Cancer Res; 2011 Mar; 13(2):R29. PubMed ID: 21396094 [TBL] [Abstract][Full Text] [Related]
12. Synergistic regulation of Schwann cell proliferation by heregulin and forskolin. Rahmatullah M; Schroering A; Rothblum K; Stahl RC; Urban B; Carey DJ Mol Cell Biol; 1998 Nov; 18(11):6245-52. PubMed ID: 9774641 [TBL] [Abstract][Full Text] [Related]
13. Stimulation of beta1-integrin function by epidermal growth factor and heregulin-beta has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinase. Adelsman MA; McCarthy JB; Shimizu Y Mol Biol Cell; 1999 Sep; 10(9):2861-78. PubMed ID: 10473632 [TBL] [Abstract][Full Text] [Related]
14. Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects. Jackson JG; St Clair P; Sliwkowski MX; Brattain MG Cancer Res; 2004 Apr; 64(7):2601-9. PubMed ID: 15059917 [TBL] [Abstract][Full Text] [Related]
15. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. Baulida J; Kraus MH; Alimandi M; Di Fiore PP; Carpenter G J Biol Chem; 1996 Mar; 271(9):5251-7. PubMed ID: 8617810 [TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells. Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850 [TBL] [Abstract][Full Text] [Related]
17. Secondary dimerization between members of the epidermal growth factor receptor family. Gamett DC; Pearson G; Cerione RA; Friedberg I J Biol Chem; 1997 May; 272(18):12052-6. PubMed ID: 9115272 [TBL] [Abstract][Full Text] [Related]
18. Presence of EGF growth factor ligands and their effects on cultured rat conjunctival goblet cell proliferation. Gu J; Chen L; Shatos MA; Rios JD; Gulati A; Hodges RR; Dartt DA Exp Eye Res; 2008 Feb; 86(2):322-34. PubMed ID: 18155194 [TBL] [Abstract][Full Text] [Related]
19. The EGF receptor binding of recombinant heregulinbeta1/EGF hybrids is blocked by heregulin residue glutamate 195. Chau BN; Nandagopal K; Niyogi SK; Campion SR Biochem Biophys Res Commun; 1996 Dec; 229(3):882-6. PubMed ID: 8954988 [TBL] [Abstract][Full Text] [Related]
20. ErbB3 and ErbB2/neu mediate the effect of heregulin on acetylcholine receptor gene expression in muscle: differential expression at the endplate. Altiok N; Bessereau JL; Changeux JP EMBO J; 1995 Sep; 14(17):4258-66. PubMed ID: 7556067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]